Patricia Keegan

15.4k citations
140 papers · 9.3k indexed · 4 hit papers · h-index 54
Topics
Lung Cancer Treatments and Mutations (32 papers)Cancer Immunotherapy and Biomarkers (31 papers)Cardiac Valve Diseases and Treatments (27 papers)
Journals
New England Journal of MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología
Partner nations
United StatesCanadaChina

In The Last Decade

Patricia Keegan

135 papers receiving 9.1k citations

Hit Papers

FDA Approval Summary: Pembrolizumab for the Treatment of ...20162026201920222019201720162016250500750

Peers

Patricia Keegan
Comparison fields: 5 of 140
  • Oncology 5.0k
  • Pulmonary and Respiratory Medicine 3.1k
  • Molecular Biology 2.1k
  • Cancer Research 1.6k
  • Immunology 1.3k
Replace Rajeshwari Sridhara with:
Rajeshwari Sridhara United States
Zhengjia Chen United States
Vivek Subbiah United States
Xavier Pivot France
Siqing Fu United States
Christophe Massard France
Afshin Dowlati United States
Gideon M. Blumenthal United States
Stefan Sleijfer Netherlands
George R. Blumenschein United States
Patricia Keegan relative to Rajeshwari Sridhara United States Rajeshwari Sridhara's profile →
Citations per field
00.5×1.6×
Rajeshwari Sridhara · 1×
Citations per year

Countries citing papers authored by Patricia Keegan

Since Specialization
Citations

This map shows the geographic impact of Patricia Keegan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Keegan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Keegan more than expected).

Fields of papers citing papers by Patricia Keegan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Keegan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Keegan. The network helps show where Patricia Keegan may publish in the future.

Co-authorship network of co-authors of Patricia Keegan

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Keegan. A scholar is included among the top collaborators of Patricia Keegan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Keegan. Patricia Keegan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 0
4 24
5 8
6 61
7 23
8 20
9 166
10 15
11 6
12 112
13 1
14 49
15 8
16 10
17 18
18 230
19 21
20 13

About Patricia Keegan

Patricia Keegan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine, having authored 140 papers that have together received 9.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (32 papers), Cancer Immunotherapy and Biomarkers (31 papers) and Cardiac Valve Diseases and Treatments (27 papers). The work is most often cited by research in Oncology (5.0k citations), Cancer Research (1.6k citations) and Pulmonary and Respiratory Medicine (3.1k citations). Patricia Keegan has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Richard Pazdur, Steven J. Lemery, Martin H. Cohen, Gideon M. Blumenthal, Kun He, Leigh Marcus, Dickran Kazandjian, Hong Zhao, Yuan Li Shen and Rajeshwari Sridhara. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026